Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-27T22:11:24.170Z Has data issue: false hasContentIssue false

Section 6 - Transitional Cell Tumors

Published online by Cambridge University Press:  12 February 2019

Edited by
Maria Rosaria Raspollini  and
Antonio Lopez-Beltran
Maria Rosaria Raspollini
Affiliation:
University Hospital Careggi, Florence
Antonio Lopez-Beltran
Affiliation:
Cordoba University Medical School
Get access
Type
Chapter
Information
Gynecologic and Urologic Pathology
Similarities, Differences and Challenges
 , pp. 245 - 282
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Gilks, C.B., Carinelli, S.G., Liu, A., et al. Brenner tumours (Chapter 1: Tumours of the ovary). In: Kurman, R.J., Carcangiu, M.L., Herrington, C.S., Young, R.H., editors, WHO Classification of Tumours of Female Reproductive Organs, 4th edn.Lyon: IARC; 2014, p. 35–37.Google Scholar
Scully, R.E., Young, R.H., Clement, P.B.. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In: Atlas of Tumor Pathology. Third series. Fascicle 23. Washington, DC: Armed Forces Institute of Pathology; 1998, p. 153–164.Google Scholar
Logani, S., Oliva, E., Amin, M.B., et al. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications. Am J Surg Pathol 2003; 27: 1434–1441.Google Scholar
Soslow, R.A., Rouse, R.V., Hendrickson, M.R., Silva, E.G., Longacre, T.A.. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis. Int J Gynecol Pathol 1996; 15: 257–265.Google Scholar
Ogawa, K., Johansson, S.L., Cohen, S.M.. Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract. Am J Pathol 1999; 155: 1047–1050.Google Scholar
Obata, K., Morland, S.J., Watson, R.H., et al. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 1998; 58: 2095–2097.Google Scholar
Ordonez, N.G.. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol 1998; 22: 1203–1214.Google Scholar
Ordonez, N.G., Mackay, B.. Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder. Ultrastruct Pathol 2000; 24: 157–167.Google Scholar
Prat, J., Matias-Guiu, X., Barreto, J.. Simultaneous carcinoma involving the endometrium and the ovary: a clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases. Cancer 1991; 68: 2455–2459.Google Scholar
Scurry, J.P., Brown, R.W., Jobling, T.. Combined ovarian serous papillary and hepatoid carcinoma. Gynecol Oncol 1996; 63: 138–142.CrossRefGoogle ScholarPubMed
Cuatrecasas, M., Erill, N., Musulen, E., et al. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathological study of 144 patients. Cancer 1998; 82: 1088–1095.Google Scholar
Riedel, I., Czernobilsky, B., Lifschitz-Mercer, B., et al. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchows Arch 2001; 438: 181–191.CrossRefGoogle Scholar
Cuatrecasas, M., Catasus, L., Palacios, J., Prat, J.. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am J Surg Pathol 2009; 33: 556–567.Google Scholar
Ali, R.H., Seidman, J.D., Luk, M., et al. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant Brenner tumor. Int J Gynecol Pathol 2012; 31: 499–506.Google Scholar
Austin, R.M., Norris, H.J.. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison. Int J Gynecol Pathol 1987; 6: 29–39.Google Scholar
Roth, L.M., Gersell, D.J., Ulbright, T.M.. Ovarian Brenner tumors and transitional cell carcinoma: recent developments. Int J Gynecol Pathol 1993; 12: 128–133.CrossRefGoogle ScholarPubMed
Silva, E.G., Robey-Cafferty, S.S., Smith, T.L., Gershenson, D.M.. Ovarian carcinomas with transitional cell carcinoma pattern. Am J Clin Pathol 1990; 93: 457–465.Google Scholar
Eichhorn, J.H., Young, R.H.. Transitional cell carcinoma of the ovary: a study of its morphology in 100 cases. Am J Surg Pathol 2004; 28: 453–463.Google Scholar
Gersell, D.J.. Primary ovarian transitional cell carcinoma: diagnostic and prognostic considerations (Editorial). Am J Clin Pathol 1990; 93: 586–588.Google Scholar
Parker, D.C., Folpe, A.L., Bell, J., et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol 2003; 27: 1–10.Google Scholar
Ordonez, N.G.. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different. Histopathology 2000; 36: 433–438.Google Scholar
Hollingsworth, H.C., Steinberg, S.M., Silverberg, S.G., Merino, M.J.. Advanced stage transitional cell carcinoma of the ovary. Hum Pathol 1996; 27: 1267–1272.Google Scholar

References

Moch, H., Humphrey, P., Ulbright, T.M., Reuter, V.E. (editors). WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th edn. Lyon: IARC; 2016.Google Scholar
Mazzucchelli, R., Scarpelli, M., Lopez-Beltran, A., et al. A contemporary update on pathology reporting for urinary bladder cancer. Int J Immunopathol Pharmacol 2012; 25: 565–571.Google Scholar
Mazzucchelli, R., Cheng, L., Lopez-Beltran, A., Scarpelli, M., Montironi, R.. Classification and grading of noninvasive and invasive neoplasms of the urothelium. Anal Quant Cytol Histol 2012; 34: 111–119.Google Scholar
Montironi, R., Lopez-Beltran, A., Scarpelli, M., Mazzucchelli, R., Cheng, L.. Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. Histopathology 2008; 53: 621–633.Google Scholar
Cheng, L., Cheville, J.C., Neumann, R.M., Bostwick, D.G.. Natural history of urothelial dysplasia of the bladder. Am J Surg Pathol 1999; 23: 443–447.Google Scholar
Cheng, L., Montironi, R., Davidson, D.D., Lopez-Beltran, A.. Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol 2009; 22: S70–S95.Google Scholar
Lopez-Beltran, A., Cheng, L., Andersson, L., et al. Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation. Virchows Arch 2002; 440: 3–11.Google Scholar
Giunchi, F., Vasuri, F., Vagnoni, V., et al. Unusual asymptomatic presentation of bladder cancer metastatic to the penis. Pathol Res Pract 2017; 213: 717–720.Google Scholar
Lee, T.K., Chaux, A., Karram, S., et al. Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center. Hum Pathol 2011; 42: 1799–1803.Google Scholar
Lopez-Beltran, A., Algaba, F., Berney, D.M., et al. Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology 2011; 58: 579–585.Google Scholar
Epstein, J.I., Amin, M.B.. Urothelial neoplasms with inverted growth patterns. In Epstein, J.I., Amin, M.B., editors, Biopsy Interpretation of the Bladder. Philadelphia, PA: Lippincot Williams & Wilkins; 2010, p.79–93.Google Scholar
Lopez-Beltran, A., Cheng, L.. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol 2006; 37(11): 1371–1388.Google Scholar
Billis, A., Schenka, A.A., Ramos, C.C., Carneiro, L.T., Araújo, V.. Squamous and/or glandular differentiation in urothelial carcinoma: prevalence and significance in transurethral resections of the bladder. Int Urol Nephrol 2001; 33: 631–633.Google Scholar
Wasco, M.J., Daignault, S., Zhang, Y., et al. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 2007; 70: 69–74.Google Scholar
Jozwicki, W., Domaniewski, J., Skok, Z., et al. Usefulness of histologic homogeneity estimation of muscle invasive urinary bladder cancer in an individual prognosis: a mapping study. Urology 2005; 66: 1122–1126.Google Scholar
Amin, M.B., Edge, S., Greene, F., et al. (editors). AJCC Cancer Staging Manual, 8th edn. New York: Springer; 2017.Google Scholar
Raspollini, M.R., Sardi, I., Giunti, L., et al. Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathological, immunohistochemical, ultrastructural, and molecular analysis of a case series. Hum Pathol 2011; 42: 1149–1158.Google Scholar
Paner, G.P., Ro, J.Y., Wojcik, E.M., et al. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 2007; 31: 1420–1429.Google Scholar
Platz, C.E., Cohen, M.B., Jones, M.P., Olson, D.B., Lynch, C.F.. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 1996; 9: 1035–1039.Google Scholar
Dixon, J.S., Gosling, J.A.. Histology and fine structure of the muscularis mucosae of the human urinary bladder. J Anat 1983; 13: 265–271.Google Scholar
Keep, J.C., Piehl, M., Miller, A., Oyasu, R.. Invasive carcinomas of the urinary bladder. Evaluation of tunica muscularis mucosae involvement. Am J Clin Pathol 1989; 91: 575–579.Google Scholar
Weaver, M.G., Abdul-Karim, F.W.. The prevalence and character of the muscularis mucosae of the human urinary bladder. Histopathology 1990; 17: 563–644.Google Scholar
Lopez-Beltran, A., Montironi, R., Cheng, L.. Pathology of the Urinary Bladder: An Algorithmic Approach. Cambridge UK: Cambridge University Press; 2016.Google Scholar
Tilki, D., Reich, O., Karakiewicz, P.I., et al. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. Eur Urol 2010; 58: 112–117.Google Scholar
Boudreaux, K.J. Jr., Chang, S.S., Lowrance, W.T., et al. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Cancer 2009; 115: 770–775.CrossRefGoogle ScholarPubMed
Tilki, D., Svatek, R.S., Karakiewicz, P.I., et al. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder. J Urol 2010; 184: 470–474.Google Scholar
Mazzucchelli, R., Cheng, L., Lopez-Beltran, A., Scarpelli, M., Montironi, R.. Clinicopathological significance of lymphovascular invasion in urothelial carcinoma. Anal Quant Cytol Histol 2012; 34: 173–179.Google Scholar
Cheville, J.C., Dundore, P.A., Bostwick, D.G., et al. Transitional cell carcinoma of the prostate: clinicopathological study of 50 cases. Cancer 1998; 82: 703–707.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Shen, S.S., Lerner, S.P., Muezzinoglu, B., et al. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 2006; 37: 726–734.Google Scholar
Fang, A.C., Ahmad, A.E., Whitson, J.M., et al. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer 2010; 116: 1901–1908.CrossRefGoogle ScholarPubMed
Stephenson, A.J., Gong, M.C., Campbell, S.C., Fergany, A.F., Hansel, D.E.. Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer. Urology 2010; 75: 382–386.Google Scholar
Fleischmann, A., Thalmann, G.N., Markwalder, R.. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 2005; 23: 2358–2365.Google Scholar

References

Al-Nafussi, A.I., Al-Yusif, R.. Papillary squamotransitional cell carcinoma of the uterine cervix: an advanced stage disease despite superficial location: report of two cases and review of the literature. Eur J Gynaecol Oncol 1998; 19: 455–457.Google Scholar
Albores-Saavedra, J., Young, R.H.. Transitional cell neoplasms (carcinomas and inverted papillomas) of the uterine cervix: a report of five cases. Am J Surg Pathol 1995; 19: 1138–1145.Google Scholar
Brink, U., Jakob, C., Bau, O., et al. Papillary squamous cell carcinoma of the uterine cervix: report of three cases and a review of its classification. Int J Gynecol Pathol 2000; 19: 231–235.Google Scholar
Koenig, C., Turnick, R.P., Kankam, C.F., et al. Papillary squamotransitional cell carcinoma of the cervix: a report of 32 cases. Am J Surg Pathol 1997; 21: 915–921.Google Scholar
Rose, P.G., Stoler, M.H., Abdul-Karim, F.W.. Papillary squamotransitional cell carcinoma of the vagina. Int J Gynecol Pathol 1998; 17: 372–375.Google Scholar
Mondaini, N., Giubilei, G., Raspollini, M.R., et al. Recurrence of vaginal implantation of transitional cell carcinoma of the urinary tract. Gynecol Oncol 2005; 97: 669–670.Google Scholar
Weir, M.M., Bell, D.A., Young, R.H.. Transitional cell metaplasia of the uterine cervix and vagina: an underrecognized lesion that may be confused with high-grade dysplasia: a report of 59 cases. Am J Surg Pathol 1997; 22: 849–862.Google Scholar
Kim, K.-R., Park, K.-H., Kin, J.-W., et al. Transitional cell metaplasia and ectopic prostatic tissue in the uterine cervix and vagina in a patient with adrenogenital syndrome: reportof a case suggesting a possible role of androgen in the histogenesis. Int J Gynecol Pathol 2004; 23: 182–187.Google Scholar
Westenend, P.J., Stoop, J.A., Hendriks, J.G.. Human papillomaviruses 6/11, 16/18 and 31/33/51 are not associated with squamous cell carcinoma of the urinary bladder. BJU Int 2001; 88: 198–201.Google Scholar
Walther, M., O’Brien, D.P. III, Birch, H.W.. Condylomata acuminata and verrucous carcinoma of the bladder: case report and literature review. J Urol 1986; 135: 362–365.Google Scholar
Cheng, L., Leibovich, B.C., Cheville, J.C., et al. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer 2000; 88: 1679–1686.Google Scholar
Frega, A., Lukic, A., Nobili, F., et al. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role duing follow-up. Anticancer Res 2007; 27: 4491–4494.Google Scholar
Lewin, F., Cardoso, A.P.G., Simardi, L.H., et al. Verrucous carcinoma of the bladder with koilocytosis unassociated with vesical schistosomiasis. Sao Paulo Med J 2004; 122: 64–66.Google Scholar
Batta, A.G., Engen, D.E., Reiman, H.M., Winkelmann, R.K.. Intra-vesical condyloma acuminatum with progression to verrucous carcinoma. Urology 1990; 36: 457–464.Google Scholar

References

Amin, M.B., Ro, J.Y., el-Sharkawy, T., et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder: histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 1994; 18: 1224–1232.Google Scholar
Moch, H., Humphrey, P.A., Ulbright, T.M., Reuter, V.E.. WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th edn, Vol. 8. Lyon: IARC Press; 2016.Google Scholar
Lopez-Beltran, A., Montironi, R., Blanca, A., Cheng, L.. Invasive micropapillary urothelial carcinoma of the bladder. Hum Pathol 2010; 41: 1159–1164.Google Scholar
Guo, C.C., Tamboli, P., Czerniak, B.. Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases. Arch Pathol Lab Med 2009; 133: 62–66.Google Scholar
Holmang, S., Thomsen, J., Johansson, L.. Micropapillary carcinoma of the renal pelvis and ureter. J Urol 2006; 175: 463–467.Google Scholar
Sangoi, A.R., Beck, A.H., Amin, M.B., et al. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol 2010; 34: 1367–1376.Google Scholar
Lopez-Beltran, A., Cheng, L.. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol 2006; 37: 1371–1388.Google Scholar
Kamat, A.M., Dinner, C.P., Gee, J.R., et al. Micropapillary bladder cancer: a review of the University of Texas MD Anderson Cancer Center experience with 100 consecutive patients. Cancer 2007; 110: 62–67.Google Scholar
Kamat, A.M., Dinner, C.P., Gee, J.R., et al. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol 2006; 175: 881–885.Google Scholar
Sui, W., Matulay, J.T., James, M.B., et al. Micropapillary bladder cancer: insights from the National Cancer Database. Bladder Cancer 2016; 2: 415–423.Google Scholar
Lim, M., Adsay, N.V., Grignon, D., et al. Urothelial carcinoma with villoglandular differentiation: a study of 14 cases. Mod Pathol 2009; 22: 1280–1286.Google Scholar
Fernández, M.I., Williams, S.B., Willis, D.L., et al. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer. BJU Int 2017; 119: 684–691.Google Scholar
Samaratunga, H., Khoo, K.. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology 2004; 45: 55–64.Google Scholar
Nguyen, D., Taheri, D., Springer, S., et al. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma. Virchows Arch 2016; 469: 427–434.Google Scholar
Maranchie, J.K., Bouyounes, B.T., Zhang, P.L., et al. Clinical and pathological characteristics of micropapillary transitional cell carcinoma: a highly aggressive variant. J Urol 2000; 163: 748–751.Google Scholar
Lopez-Beltran, A., Montironi, R., Blanca, A., Cheng, L.. Invasive micropapillary urothelial carcinoma of the bladder. Hum Pathol 2010; 41: 1159–1164.Google Scholar
Bertz, S., Wach, S., Taubert, H., et al. Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy. Virchows Arch 2016; 469: 339–344.Google Scholar
Goodman, A.L., Osunkoya, A.O.. Human epidermal growth factor receptor 2 expression in micropapillary urothelial carcinoma of the bladder: an analysis of 27 cases. Hum Pathol 2016; 57: 160–164.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×